Literature DB >> 33464951

Response by Methawasin and Granzier to Letter Regarding Article, "Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction".

Mei Methawasin1, Henk Granzier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33464951      PMCID： PMC7839309          DOI： 10.1161/CIRCHEARTFAILURE.120.007755

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  5 in total

1.  Beta-adrenergic signaling in heart failure-adapt or die.

Authors:  Thomas Eschenhagen
Journal:  Nat Med       Date:  2008-05       Impact factor: 53.440

2.  Phosphodiesterase expression in the normal and failing heart.

Authors:  Edwin A Li; Wang Xi; Young Soo Han; Frank V Brozovich
Journal:  Arch Biochem Biophys       Date:  2018-12-11       Impact factor: 4.013

Review 3.  Tuning the molecular giant titin through phosphorylation: role in health and disease.

Authors:  Carlos Hidalgo; Henk Granzier
Journal:  Trends Cardiovasc Med       Date:  2013-01-05       Impact factor: 6.677

4.  Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.

Authors:  Mei Methawasin; Joshua Strom; Tomasz Borkowski; Zaynab Hourani; Ray Runyan; John E Smith; Henk Granzier
Journal:  Circ Heart Fail       Date:  2020-05-18       Impact factor: 8.790

5.  Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.

Authors:  Sarah Karam; Jean Piero Margaria; Aurélia Bourcier; Delphine Mika; Audrey Varin; Ibrahim Bedioune; Marta Lindner; Kaouter Bouadjel; Matthieu Dessillons; Françoise Gaudin; Florence Lefebvre; Philippe Mateo; Patrick Lechène; Susana Gomez; Valérie Domergue; Pauline Robert; Charlène Coquard; Vincent Algalarrondo; Jane-Lise Samuel; Jean-Baptiste Michel; Flavien Charpentier; Alessandra Ghigo; Emilio Hirsch; Rodolphe Fischmeister; Jérôme Leroy; Grégoire Vandecasteele
Journal:  Circulation       Date:  2020-04-08       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.